Disparities in Adjuvant Radioactive Iodine Use in High-Risk Follicular Thyroid Carcinoma: Evaluation of NCCN and ATA Guideline Concordance
- 23 April 2026
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 324, 295-303
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The association of community-level social vulnerability with access to high-volume endocrine surgeonsSurgery, 2025
- Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trialThe Lancet Diabetes & Endocrinology, 2024
- The Impact of Race and the Affordable Care Act on Thyroid Carcinoma Outcomes: A National Cancer Database StudyThe Laryngoscope, 2024
- Thyroid CancerJAMA, 2024
- The impact of social determinants of health on thyroid cancer mortality and time to treatmentSurgery, 2023
- Disparities in Treatment for Differentiated Thyroid CancerThyroid®, 2023
- Insurance type is associated with appropriate use of surgical and adjuvant care for differentiated thyroid carcinomaSurgery, 2022
- Thyroid Lobectomy for T1b-T2 Papillary Thyroid Cancer with High-Risk FeaturesJournal of the American College of Surgeons, 2020
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid CancerNew England Journal of Medicine, 2012